MedPath

FABRAZYME 5 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION

FABRAZYME 5 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION

Commercialized
Register Number

01188004

Prescription Type

Uso Hospitalario

Authorization Date

Jan 12, 2004

Dosage Form

POLVO PARA CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN

Route: VÍA INTRAVENOSA

Product Details

Detailed information about this CIMA AEMPS approved pharmaceutical product.

Basic Information

Key regulatory and product classification details

Regulatory Details

Register Number01188004
EMA Approved
Yes

Drug Classification

Generic
No
Orphan
No
Biosimilar
No
Commercialized
Yes
CIMA AEMPS Classification

INGREDIENTS (1)

AGALSIDASA BETAActive
Quantity: 5 mg
Name: AGALSIDASA BETA

ATC CLASSIFICATION (3)

A16A
A16AB
A16AB04

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.